US Patent 7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
Patent 7619096 was granted and assigned to Eli Lilly on November, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Barry Peter Clark0
Christopher David Beadle0
Graham Henry Timms0
Jeremy Gilmore0
John Joseph Masters0
Magnus Wilhelm Walter0
Manuel Javier Cases-Thomas0
Maria Ann Whatton0
Peter Thaddeus Gallagher0
Virginia Ann Wood0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+70 characters)
Article
Patent abstract
The present invention provides compounds of formula (I)
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07619096 3-Aminopyrrolidines as inhibitors of monoamine uptake US Patent 7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
Infobox
Patent Number
07619096
Patent Number
7619096
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07619096
Date of patent
November 17, 2009
Patent application number
10558626
Date Filed
May 11, 2004
Patent primary examiner
Find more entities like US Patent 7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.